News for 'drug quality'

Wockhardt told to pull out analgesic batches

Wockhardt told to pull out analgesic batches

Rediff.com14 Feb 2013

Regulator mentions Wockhardt as manufacturer but firm says it only markets drug.

What is the future of e-pharmacies in India?

What is the future of e-pharmacies in India?

Rediff.com19 Dec 2019

PharmEasy, 1mg and Netmeds believe that their disruptive capabilities will power their brands despite the recent court ruling. The Drug Controller General of India recently directed all state FDAs to stop the online sale of medicines as per a Delhi high court order of last year.

Sun Pharma to buy Ranbaxy in $3.2-billion deal

Sun Pharma to buy Ranbaxy in $3.2-billion deal

Rediff.com7 Apr 2014

Sun Pharmaceutical said Ranbaxy shareholders will get 0.8 Sun Pharma shares for each Ranbaxy share.

Now, bar coding mandatory for pharma exports

Now, bar coding mandatory for pharma exports

Rediff.com13 Jan 2011

The commerce ministry has mandated bar coding on all medicine packs meant for exports from July 1, to trace and track these medicines to its source of origin. The move is in response to quality concerns raised against Indian drugs by some African countries.

Does India have enough jabs to expand vaccination drive?

Does India have enough jabs to expand vaccination drive?

Rediff.com3 Jan 2022

A back of the envelope calculation shows that India has roughly over 680 million doses of Covid-19 vaccines consisting primarily of Covishield doses.

SC decision on Novartis to benefit poor: Pharma cos

SC decision on Novartis to benefit poor: Pharma cos

Rediff.com1 Apr 2013

Terming the judgement as a 'landmark judgement' in favour of poor patients, domestic drug manufacturer associations, including Indian Pharmaceutical Alliance and Indian Drug Manufacturers' Association, hailed the apex court's decision.

How safe are medicines made in India?

How safe are medicines made in India?

Rediff.com14 Apr 2014

Patients have become wary of India-made drugs after a number of reports highlighted their substandard quality.

Timely facilitation of COVID-19 kits will help Sino-India ties: Envoy

Timely facilitation of COVID-19 kits will help Sino-India ties: Envoy

Rediff.com14 Apr 2020

As its factories resumed operations after over two-month of grim battle against coronavirus, China is busy tapping into the vast business opportunities of export of key medical goods, specially ventilators and personal protection equipment (PPE), across the world, including India, where both private and government bodies are placing orders for the import of these products.

Cap on stent prices brings Chinese maker to India

Cap on stent prices brings Chinese maker to India

Rediff.com28 Feb 2017

MicroPort entered the market on Feb 15 and its stent was used in a Mumbai hospital.

Scientists urge caution over launch of Covid vaccine by Aug 15

Scientists urge caution over launch of Covid vaccine by Aug 15

Rediff.com4 Jul 2020

'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'

FDA raises concern over US unit: Wockhardt

FDA raises concern over US unit: Wockhardt

Rediff.com28 May 2014

Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.

Company Watch: Emami, Shriram Transport, Lupin

Company Watch: Emami, Shriram Transport, Lupin

Rediff.com8 Feb 2021

Check out some of the stocks that will react on the basis of their numbers in the near term.

Can Ranbaxy come out of the shadows?

Can Ranbaxy come out of the shadows?

Rediff.com5 Jul 2013

It has hired consultants to advise it on a strategic project and compliance issues in the US. It also needs to improve employee morale.

Bharat Biotech, Serum Institute to jointly roll out vaccines

Bharat Biotech, Serum Institute to jointly roll out vaccines

Rediff.com5 Jan 2021

In a joint statement posted on their respective twitter accounts, the companies said Serum Institute Chief Executive Officer Adar Poonawalla and Bharat Biotech Chairman Krishna Ella communicated their combined intent to develop, manufacture and supply the COVID-19 vaccines.

Conmen cash in on Covid desperation amid 2nd wave

Conmen cash in on Covid desperation amid 2nd wave

Rediff.com18 May 2021

At a time when the country's medical infrastructure has become incapable of handling the pressure of Covid's deadly second wave, a parallel wave of conmen, black marketers and counterfeiters can be witnessed across the country. Geetanjali Krishna reports.

Darlings Is Daring, Not Superficial

Darlings Is Daring, Not Superficial

Rediff.com12 Aug 2022

I cannot think of another Hindi movie that has, without so much as a hint of cynicism or speechifying, brought out that fundamental fact of Muslims being an integral part of the Indian culture while being at the same time a subculture with its own polite niceties, observes Sreehari Nair.

Pharma sector in alarm over govt's cure

Pharma sector in alarm over govt's cure

Rediff.com28 Oct 2017

The government plans to rationalise trade margins for many other medical devices, besides stents and knee implants.

Dr Reddy's sued in US court by S Korean pharma co

Dr Reddy's sued in US court by S Korean pharma co

Rediff.com27 Jan 2017

Suit alleges fraud by hiding significant deficiencies in CGMP regulations enforced by US health regulator.

Regulator finds procedural lapses at Wockhardt's US facility

Regulator finds procedural lapses at Wockhardt's US facility

Rediff.com3 Jun 2014

The FDA had imposed a ban on the company's Waluj plant in May.

Regulator might inspect Wockhardt units

Regulator might inspect Wockhardt units

Rediff.com12 Jun 2013

Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.

How India's pharma growth story fizzled out

How India's pharma growth story fizzled out

Rediff.com5 Jul 2017

Once tipped to emerge as the biggest exporter, the pharmaceutical industry is yet to acquire the scale of those in software services, says Krishna Kant.

India, Canada to tap pharma opportunities

India, Canada to tap pharma opportunities

Rediff.com23 Nov 2007

The drug regulatory agencies of India and Canada are planning to collaborate on improving the quality of drugs traded between the two countries, besides helping the industry in both the countries to tap the opportunities in the field of generic medicines and drug development.

Drugmakers draw more FDA scrutiny as US imports rise

Drugmakers draw more FDA scrutiny as US imports rise

Rediff.com13 Sep 2013

And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.

Covid vaccine possible by 2021 first quarter: Vardhan

Covid vaccine possible by 2021 first quarter: Vardhan

Rediff.com13 Sep 2020

Vardhan stated the government is taking full precautions in human trials of vaccines and the National Expert Group on Vaccine Administration for COVID-19 under the chairmanship of Dr V K Paul, member-health, NITI Aayog, is drawing up a detailed strategy on how to immunize the majority of the population.

10 Reasons Why Men FAIL at SEX

10 Reasons Why Men FAIL at SEX

Rediff.com6 May 2021

Men tend to consider sex as a way to impress their partner. When they give this thinking a great deal of importance, it turns into what is generally called performance anxiety, cautions Rajat Jadhav

The WORST FILMS of 2021

The WORST FILMS of 2021

Rediff.com1 Jan 2022

Every year, with the good, there are bad movies too.

We are safe only when everyone is safe

We are safe only when everyone is safe

Rediff.com7 Jul 2021

So vaccinate employees and families, staff at home, rickshaw drivers, milkmen, service providers, shopkeepers and street vendors, says Naushad Forbes.

Indian companies not singled out for inspections: USFDA

Indian companies not singled out for inspections: USFDA

Rediff.com18 Mar 2015

A global policy would reward firms which strive for higher quality.

Answered: When COVID-19 will end

Answered: When COVID-19 will end

Rediff.com24 Jul 2020

'"The end" depends on two things.' 'Either you develop a vaccine which is effective or if you have a drug, you can terminate this infection very quickly.' 'Otherwise, you have to depend on herd immunity.' 'I think it should happen earlier. Far earlier, than we can imagine or achieve 'herd immunity'.'

USFDA rejected 12,012 Indian products since January 2011

USFDA rejected 12,012 Indian products since January 2011

Rediff.com2 May 2016

The reasons given for the refusal include misbranding, adulteration, packaging, labelling, pesticides, unapproved products.

Pandemic brings windfall for e-pharma companies

Pandemic brings windfall for e-pharma companies

Rediff.com27 Aug 2020

The online pharmacy market, which was worth about $512 million in 2018, is growing at a CAGR of 63 per cent and is expected to hit overall revenues of over $3.6 billion by 2022.

Beware! Fake medicines dumped in Kerala

Beware! Fake medicines dumped in Kerala

Rediff.com4 Jul 2009

These fake medicines include several life-saving drugs, as well as common medicines like Paracetamol. These low-quality drugs are imported from China and freely available in the market.

Ranbaxy asks 2 execs to exit

Ranbaxy asks 2 execs to exit

Rediff.com10 Nov 2010

According to a report, the executives are T G Chandrashekhar, vice-president, global quality and analytical research, and Abha Pant, executive director for regulatory affairs.

Indian regulator also scans Ranbaxy

Indian regulator also scans Ranbaxy

Rediff.com20 Sep 2013

The move comes in the wake of many facilities of Ranbaxy in India being barred by the US Food and Drugs Administration for supplying medicines to the US.

Covaxin emergency use decision likely in 4-6 weeks: WHO

Covaxin emergency use decision likely in 4-6 weeks: WHO

Rediff.com10 Jul 2021

There is a process to be followed for EUL and pre-qualification of vaccines under which a company has to complete phase 3 trials and submit the whole data to the regulatory department of WHO which is examined by an expert advisory group," Swaminathan said.

Rosier year-end seen for Indian pharma, thanks to faster US approvals

Rosier year-end seen for Indian pharma, thanks to faster US approvals

Rediff.com12 Oct 2015

Rosier year-end seen for Indian pharma thanks to faster US approvals.

The BEST and WORST of 2021

The BEST and WORST of 2021

Rediff.com3 Jan 2022

A year marked by more lows than highs for Hindi cinema, here's a recap of the best and worst in 2021.

J&K: 66.5 kg heroin, brown sugar seized from truck on LoC

J&K: 66.5 kg heroin, brown sugar seized from truck on LoC

Rediff.com22 Jul 2017

The consignment was expected to fetch over Rs 300 crore if it had reached the market.

The secret diet to improve fertility

The secret diet to improve fertility

Rediff.com17 Mar 2018

Intake of nutrient-rich foods is crucial.